March 24 (Reuters) - Baxter International Inc BAX.N:
BAXTER - PRODUCTION OF IFOSFAMIDE RESUMED, BUT AT REDUCED CAPACITY THAT DOES NOT MEET CURRENT DEMAND
BAXTER - LIMITED SUPPLY OF IFOSFAMIDE WHICH WILL GRADUALLY IMPROVE THROUGH 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.